2m 2m 2m 2m 2m 2m 2m
ATRIUM THERAP (RNA)
NASDAQ
$8.15+$0.15 (+1.88%)
Price as of Oct 22, 2026 7:30 PM EDT- $136.8MMarket Cap
- -82.93%1-Year Change
- BiotechnologyIndustry
ATRIUM THERAP (RNA)
$8.15+$0.15 (+1.88%)
RNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.00 | ||
Change | +$0.02 (+0.25%) | ||
Open | $7.97 | ||
High | $8.32 | ||
Low | $7.96 | ||
Previous Close | $7.98 | ||
Volume | 193,208 | ||
30-Day Average Volume | 295,479 | ||
1-Week Change | 4.17% | ||
1-Month Change | -12.95% | ||
1-Year Change | -82.93% | ||
3-Year Change | 48.42% | ||
5-Year Change | -62.95% | ||
Fundamentals | |||
Shares Outstanding | 17.1M | ||
Total Assets | $280.5M | ||
Market Cap | $136.8M | ||
Enterprise Value | $64.5M | ||
Period: QTR TTM FY | |||
Revenue | $3.0M | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$20.2M | ||
EBITDA | -$19.8M | ||
Net Working Capital | $243.5M | ||
EPS | -$1.18 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||